<DOC>
	<DOCNO>NCT01798420</DOCNO>
	<brief_summary>Corticosteroid treatment diabetic patient admit COPD exacerbation expect significantly increase hemoglobin A1C level</brief_summary>
	<brief_title>Corticosteroids Hemoglobin A1C Levels Diabetic Patients With COPD Exacerbation</brief_title>
	<detailed_description>HbA1C level evaluate diabetic patient COPD exacerbation admission hospital 3-months later . Demographic , clinical , laboratory variable total steroid dose document . Age- sex-matched group diabetic patient COPD admit reason , ask participate control group . Mann-Whitney Chi square/Fischer 's exact test use compare parameter two group . Wilcoxon sign rank test use compare HbA1C level baseline 3 month later . Multi-variate linear regression analysis use find predictors increase HbA1C level patient ' group .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Diabetic patient COPD exacerbation Patients treat steroid previous 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>COPD</keyword>
	<keyword>Diabetes</keyword>
	<keyword>steroid</keyword>
	<keyword>Hemoglobin A1C DIFFERENCE</keyword>
</DOC>